Literature DB >> 3134912

Evidence for a cytotoxic T-lymphocyte alveolitis in human immunodeficiency virus-infected patients.

B Autran1, C M Mayaud, M Raphael, F Plata, M Denis, A Bourguin, J M Guillon, P Debre, G Akoun.   

Abstract

A T8 lymphocyte alveolitis occurs in HIV-positive patients, even in the absence of any lung infections or tumors. Using the monoclonal antibody (MAb) D44, the CD8+ T cells can be further subdivided into two functional subsets of cytotoxic T lymphocytes (CTL; CD8+, D44+) and suppressor T cells (CD8+, D44-). A dual fluorescence analysis of alveolar and peripheral lymphocytes has been used in HIV-positive patients without lung infections or tumors to reveal a dramatic increase in alveolar T8 lymphocytes (83%), compared to peripheral values (52%), which was mainly composed (89%) of CD8+ D44+ CTLs. Functional studies confirmed the cytolytic activity of these phenotypically defined alveolar CTLs on autologous alveolar macrophages used as target cells, excluding a natural killer-like activity. An immuno-enzyme analysis concomitantly revealed the co-expression of the p18 HIV antigen and the CD4 molecule on the autologous alveolar macrophages. These data suggest that CTL alveolitis occurs during HIV infection and is directed against HIV-infected alveolar macrophages which are presumably the targets of the locally recruited lung CTLs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134912

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

Review 1.  Cellular and humoral antigenic epitopes in HIV and SIV.

Authors:  D F Nixon; K Broliden; G Ogg; P A Broliden
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

Review 2.  Immune responses in the lung: basic principles.

Authors:  C Agostini; G Semenzato
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

Review 4.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 5.  Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract.

Authors:  T Schneider; R Ullrich; M Zeitz
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Alveolar macrophages from subjects infected with HIV-1 express macrophage inflammatory protein-1 alpha (MIP-1 alpha): contribution to the CD8+ alveolitis.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors.

Authors:  P A Moss; S L Rowland-Jones; P M Frodsham; S McAdam; P Giangrande; A J McMichael; J I Bell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

8.  Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.

Authors:  M D Grant; F M Smaill; K L Rosenthal
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Relation of HIV-I in bronchoalveolar lavage cells to abnormalities of lung function and to the presence of Pneumocystis pneumonia in HIV-I seropositive patients.

Authors:  J R Clarke; I K Taylor; J Fleming; J D Williamson; D M Mitchell
Journal:  Thorax       Date:  1993-12       Impact factor: 9.139

10.  Cytokine influence on simian immunodeficiency virus replication within primary macrophages. TNF-alpha, but not GMCSF, enhances viral replication on a per-cell basis.

Authors:  D G Walsh; C J Horvath; A Hansen-Moosa; J J MacKey; P K Sehgal; M D Daniel; R C Desrosiers; D J Ringler
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.